A Detailed Analysis of the Cosmetic Peptide Manufacturing Market Based on Growing Consumer Demand for a Wide Range of Anti-aging Products
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 224
Report ID: PMRREP33714
1. Executive Summary
1.1. Global Cosmetic Peptide Manufacturing Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Cosmetic Peptide Manufacturing Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force’s Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Cosmetic Peptide Manufacturing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Cosmetic Peptide Manufacturing Market Outlook: Product
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
3.3.3.1. Signal Peptides
3.3.3.2. Neurotransmitter Inhibitors
3.3.3.3. Carrier Peptides
3.3.3.4. Enzyme Inhibitor Peptides
3.3.3.5. Structural Peptides
3.3.3.6. Synthetic Antimicrobial Peptides (Amps)
3.3.3.7. Others
3.4. Market Attractiveness Analysis: Product
3.5. Global Cosmetic Peptide Manufacturing Market Outlook: End User
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.5.3.1. Anti-Aging
3.5.3.2. Eye Care
3.5.3.3. Anti-Pigmentation
3.5.3.4. Hair Growth
3.6. Market Attractiveness Analysis: End User
3.7. Global Cosmetic Peptide Manufacturing Market Outlook: End User
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.7.3.1. Cosmetic Manufacturers
3.7.3.2. Cosmetic Contract Manufacturers
3.7.3.3. Biopharmaceutical Industries (Personal care)
3.8. Market Attractiveness Analysis: End User
4. Global Cosmetic Peptide Manufacturing Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia & Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Cosmetic Peptide Manufacturing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Product
5.3.3. By Application
5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
5.5.1. Signal Peptides
5.5.2. Neurotransmitter Inhibitors
5.5.3. Carrier Peptides
5.5.4. Enzyme Inhibitor Peptides
5.5.5. Structural Peptides
5.5.6. Synthetic Antimicrobial Peptides (Amps)
5.5.7. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
5.6.1. Anti-Aging
5.6.2. Eye Care
5.6.3. Anti Pigmentation
5.6.4. Hair Growth
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.7.1. Cosmetic Manufacturers
5.7.2. Cosmetic Contract Manufacturers
5.7.3. Biopharmaceutical Industries (Personal care)
5.8. Market Attractiveness Analysis
6. Europe Cosmetic Peptide Manufacturing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Product
6.3.3. By Application
6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
6.5.1. Signal Peptides
6.5.2. Neurotransmitter Inhibitors
6.5.3. Carrier Peptides
6.5.4. Enzyme Inhibitor Peptides
6.5.5. Structural Peptides
6.5.6. Synthetic Antimicrobial Peptides (Amps)
6.5.7. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
6.6.1. Anti-Aging
6.6.2. Eye Care
6.6.3. Anti Pigmentation
6.6.4. Hair Growth
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.7.1. Cosmetic Manufacturers
6.7.2. Cosmetic Contract Manufacturers
6.7.3. Biopharmaceutical Industries (Personal care)
6.8. Market Attractiveness Analysis
7. East Asia Cosmetic Peptide Manufacturing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Product
7.3.3. By Application
7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
7.5.1. Signal Peptides
7.5.2. Neurotransmitter Inhibitors
7.5.3. Carrier Peptides
7.5.4. Enzyme Inhibitor Peptides
7.5.5. Structural Peptides
7.5.6. Synthetic Antimicrobial Peptides (Amps)
7.5.7. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
7.6.1. Anti-Aging
7.6.2. Eye Care
7.6.3. Anti Pigmentation
7.6.4. Hair Growth
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.7.1. Cosmetic Manufacturers
7.7.2. Cosmetic Contract Manufacturers
7.7.3. Biopharmaceutical Industries (Personal care)
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Cosmetic Peptide Manufacturing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Product
8.3.3. By Application
8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
8.5.1. Signal Peptides
8.5.2. Neurotransmitter Inhibitors
8.5.3. Carrier Peptides
8.5.4. Enzyme Inhibitor Peptides
8.5.5. Structural Peptides
8.5.6. Synthetic Antimicrobial Peptides (Amps)
8.5.7. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
8.6.1. Anti-Aging
8.6.2. Eye Care
8.6.3. Anti Pigmentation
8.6.4. Hair Growth
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.7.1. Cosmetic Manufacturers
8.7.2. Cosmetic Contract Manufacturers
8.7.3. Biopharmaceutical Industries (Personal care)
8.8. Market Attractiveness Analysis
9. Latin America Cosmetic Peptide Manufacturing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
9.5.1. Signal Peptides
9.5.2. Neurotransmitter Inhibitors
9.5.3. Carrier Peptides
9.5.4. Enzyme Inhibitor Peptides
9.5.5. Structural Peptides
9.5.6. Synthetic Antimicrobial Peptides (Amps)
9.5.7. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
9.6.1. Anti-Aging
9.6.2. Eye Care
9.6.3. Anti Pigmentation
9.6.4. Hair Growth
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.7.1. Cosmetic Manufacturers
9.7.2. Cosmetic Contract Manufacturers
9.7.3. Biopharmaceutical Industries (Personal care)
9.8. Market Attractiveness Analysis
10. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
10.5.1. Signal Peptides
10.5.2. Neurotransmitter Inhibitors
10.5.3. Carrier Peptides
10.5.4. Enzyme Inhibitor Peptides
10.5.5. Structural Peptides
10.5.6. Synthetic Antimicrobial Peptides (Amps)
10.5.7. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application,2023 - 2030
10.6.1. Anti-Aging
10.6.2. Eye Care
10.6.3. Anti Pigmentation
10.6.4. Hair Growth
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.7.1. Cosmetic Manufacturers
10.7.2. Cosmetic Contract Manufacturers
10.7.3. Biopharmaceutical Industries (Personal care)
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Neurotransmitter Inhibitors
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Croda International Plc
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Ashland
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. DSM [Koninklijke DSM NV]
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Bachem
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Genscript Biotech Corp
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. BASF SE
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Geltor
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. The Lubrizol Corporation
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Symrise
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Bio basic Inc.
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Regeron Inc.
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
